Clinical Trial Update: HAIC Combined with PD-1 Inhibitor in Potentially Resectable Locally Advanced HCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hepatic arterial infusion chemotherapy (HAIC) combined with a PD-1 inhibitor for potentially resectable locally advanced hepat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• PD-1 inhibitor

Snippet

Sponsor: Sun Yat-sen University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING